Schedule 13G ownership disclosure

NEUROONE MED TECHNOLOGIES CO

Common Stock, par value $0.001 · CUSIP: 64130M209

Event date: 2025-03-31

Filing-level shares
1,295,288.00
Percent of class
2.6%
  • LYTTON LAURENCE W

    Shares: 1,295,288.00 · Class: 2.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000373
Form type
SCHEDULE 13G/A
Filer
LYTTON LAURENCE W
CIK
CIK 1105806
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub